Kelly Deck - 03 Jan 2023 Form 4 Insider Report for Inhibrx, Inc.

Role
Chief Financial Officer
Signature
/s/ Kelly D. Deck, attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
03 Jan 2023, 17:09:40 UTC
Previous filing
25 Jan 2022
Next filing
06 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 03 Jan 2023 Common Stock 30,000 $23.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.